Tyra Biosciences (TYRA) Non-Current Assets (2020 - 2026)

Tyra Biosciences has reported Non-Current Assets for 7 years, with the latest figure at $17.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 7.84% year-over-year to $17.4 million; the trailing twelve-month figure through Mar 2026 stood at $74.6 million (up 16.74% YoY), and the FY2025 full-year result was $17.2 million, up 6.61% from the prior year.
• Non-Current Assets for Q1 2026 stood at $17.4 million, up from $17.2 million in the prior quarter.
• The five-year high for Non-Current Assets was $20.6 million in Q3 2025, with the low at $4.9 million in Q1 2022.
• Historically, Non-Current Assets has averaged $13.5 million across 5 years, with a median of $14.0 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 244.84% — and 2026, when it dropped 7.84%.
• Tyra Biosciences' Non-Current Assets stood at $8.9 million in 2022, then jumped by 59.52% to $14.2 million in 2023, then increased by 13.46% to $16.1 million in 2024, then gained by 6.61% to $17.2 million in 2025, then climbed by 1.56% to $17.4 million in 2026.
• The last three Non-Current Assets figures came in at $17.4 million (Q1 2026), $17.2 million (Q4 2025), and $20.6 million (Q3 2025), per Business Quant data.